Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MRGPRX4 | Q96LA9 | 8/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | CD274 | Q9NZQ7 | 6/20 | 0.38 |
| ▸ | PDCD1 | Q15116 | 5/20 | 0.38 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.36 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.36 |
| ▸ | CLCN2 | P51788 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.35 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5075839 | 0.92 | MRGPRX4 (0.43) | MRGPRX4TP53HTTCD274PDCD1 | |
| SCHEMBL5079666 | 0.87 | PDCD1 (0.49) | MRGPRX4TP53HTTCD274PDCD1 | |
| SCHEMBL5076349 | 0.86 | HTT (0.37) | MRGPRX4TP53HTTCD274S1PR1 | |
| SCHEMBL5074544 | 0.86 | TP53 (0.37) | MRGPRX4TP53HTTCD274S1PR1 | |
| SCHEMBL6149439 | 0.86 | MRGPRX4 (0.44) | MRGPRX4TP53HTTCD274PDCD1 | |
| SCHEMBL6149441 | 0.83 | MRGPRX4 (0.42) | MRGPRX4TP53HTTCD274PDCD1 | |
| SCHEMBL6149436 | 0.83 | MRGPRX4 (0.42) | MRGPRX4TP53HTTCD274PDCD1 | |
| SCHEMBL6151025 | 0.83 | HIF1A (0.43) | MRGPRX4TP53HTTCD274PDCD1 | |
| SCHEMBL6151029 | 0.83 | HIF1A (0.43) | MRGPRX4TP53HTTCD274PDCD1 | |
| SCHEMBL5080387 | 0.83 | MRGPRX4 (0.41) | MRGPRX4TP53HTTCD274PDCD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7435844-B2 | Analogous compounds of strobilurines and their use as acaricides and insecticides | ISAGRO RICERCA S.R.L. (IT) | 2008-10-14 | — | — | US | disclosed |
| US-20060235075-A1 | Analogous compounds of strobilurines and their use as acaricides and insecticides | ISAGRO RICERCA S.R.L. (IT) | 2006-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060235075-A1 | Analogous compounds of strobilurines and their use as acaricides and insecticides | DDT, RYR1, TPMT | MRGPRX4 989/4885TP53 2842/4885HTT 4420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.